Genetic Engineering & Biotechnology News: Bacterial Platforms Can Rival Mammalian Platforms
Jun 05, 2021
Absci CEO and Founder Sean McClain spoke with GEN about how its Escherichia coli platforms are engineered to defy known cell line limitations and enable high-titer scale-up of challenging biologics. Read more.